Skip to main content
. 2015 Dec 15;4(3):441–449. doi: 10.3892/mco.2015.712

Figure 1.

Figure 1.

The positive rate of CEA, CA19-9, and CA72-4, and a parallel test of three tumor biomarkers in all patients and in subgroups. M, male; F, female; y, years; Dif, differentiated; Undif, undifferentiated; T, tumor stage; N, lymph node stage; M; M stage; CEA, carcinoembryonic antigen; CA19-9, carbohydrate antigen 19-9; CA72-4, carbohydrate antigen 72-4; PARA, parallel test.